|
|||||
|
|

Flow control equipment manufacturer Flowserve (NYSE:FLS) missed Wall Street’s revenue expectations in Q3 CY2025 as sales rose 3.6% year on year to $1.17 billion. Its non-GAAP profit of $0.90 per share was 13.2% above analysts’ consensus estimates.
Is now the time to buy FLS? Find out in our full research report (it’s free for active Edge members).
Flowserve’s third quarter results drew a positive response from the market, reflecting progress in margin expansion and continued growth in key business areas. Management pointed to robust aftermarket bookings and notable advances in the power and nuclear segments as major contributors. CEO Robert Rowe credited the “Flowserve Business System” and the company’s 80/20 complexity reduction program for driving higher adjusted gross margins despite ongoing project timing challenges in the energy sector. The quarter also saw increased cash generation, which enabled additional share repurchases and a strengthened balance sheet.
Looking ahead, Flowserve’s updated full-year guidance is anchored by confidence in nuclear power demand and ongoing operational improvements. Management emphasized anticipated double-digit growth in nuclear, citing Flowserve’s installed base in 75% of global reactors and high barriers to entry in this market. CFO Amy Schwetz noted that the recent divestiture of legacy asbestos liabilities will further simplify capital allocation, stating, “We now have more opportunities for capital allocation than ever before.” The company remains focused on capturing aftermarket growth, margin expansion, and leveraging its broad portfolio to support continued profitability.
Management attributed the quarter’s performance to strength in nuclear project bookings, progress in aftermarket services, and successful execution of operational efficiency programs, while also addressing the impact of project mix shifts and selective bidding in large energy projects.
Management expects continued strength in nuclear power and aftermarket services to drive growth, while operational discipline and selective bidding in large projects shape the margin outlook.
Looking to future quarters, our team will closely watch (1) the pace of nuclear project bookings and Flowserve’s ability to capture new reactor and life extension work, (2) sustained strength and profitability in the aftermarket business, and (3) margin progression as operational excellence programs mature and synergies from recent acquisitions, such as Mogas, are realized. Execution on capital allocation and backlog conversion will also be important indicators.
Flowserve currently trades at $69.41, up from $52.65 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free for active Edge members).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-26 | |
| Oct-23 | |
| Oct-22 | |
| Oct-22 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite